By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Isis Pharmaceuticals, Inc. 

Carlsbad Research Center
2292 Faraday Avenue
Carlsbad  California  92008-7208  U.S.A.
Phone: 760-931-9200 Fax: 760-603-4650


SEARCH JOBS


Industry
Biotechnology






Company News
Isis Pharmaceuticals, Inc. (ISIS) Initiates Phase 3 Study Of ISIS-APOCIII Rx In Patients With FCS 8/28/2014 11:34:02 AM
Isis Pharmaceuticals, Inc. (ISIS) Earns $2 Million From The Advancement Of ISIS-SMN Rx In Children With Spinal Muscular Atrophy 8/15/2014 8:59:06 AM
Isis Pharmaceuticals, Inc. (ISIS) Reports Financial Results And Highlights For Second Quarter 2014 8/4/2014 8:54:13 AM
Isis Pharmaceuticals, Inc. (ISIS) Initiates Phase 3 Study Of ISIS-SMN Rx In Infants With Spinal Muscular Atrophy 8/1/2014 7:11:55 AM
Webcast Alert: Isis Pharmaceuticals, Inc. (ISIS)' Second Quarter 2014 Financial Results Conference Call 7/28/2014 8:37:28 AM
Isis Pharmaceuticals, Inc. (ISIS) Initiates Phase 2 Study Of ISIS-APO(a) Rx In Patients With High Lp(a) 7/17/2014 9:38:10 AM
Isis Pharmaceuticals, Inc. (ISIS) Earns $1 Million From GlaxoSmithKline (GSK) For Advancing ISIS-TTR Rx 7/16/2014 9:05:47 AM
Isis Pharmaceuticals, Inc. (ISIS) Earns $1 Million From GlaxoSmithKline (GSK) For Advancing Hepatitis B Virus Program 7/2/2014 8:25:29 AM
Isis Pharmaceuticals, Inc. (ISIS) Earns $1 Million From GlaxoSmithKline (GSK) For Advancing ISIS-TTR Rx 6/24/2014 6:54:03 AM
Isis Pharmaceuticals, Inc. (ISIS) Could Get $2 Billion Gain From Heart Attack Trials 6/20/2014 7:09:10 AM
12345678910...
//-->